Market capitalization | $36.20m |
Enterprise Value | $415.02m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 10.44 |
P/S ratio (TTM) P/S ratio | 0.91 |
P/B ratio (TTM) P/B ratio | 0.15 |
Revenue growth (TTM) Revenue growth | -21.40% |
Revenue (TTM) Revenue | $39.75m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
4 Analysts have issued a Danimer Scientific forecast:
4 Analysts have issued a Danimer Scientific forecast:
Jun '24 |
+/-
%
|
||
Revenue | 40 40 |
21%
21%
|
|
Gross Profit | -36 -36 |
29%
29%
|
|
EBITDA | -70 -70 |
29%
29%
|
EBIT (Operating Income) EBIT | -99 -99 |
20%
20%
|
Net Profit | -130 -130 |
35%
35%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Danimer Scientific, Inc. operates as a next generation bioplastics company. It focuses on the development and production of biodegradable materials. The firm sells its products under the brand name Nodax. Its applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles. The company was founded on January 13, 2014 and is headquartered in Bainbridge, GA.
Head office | United States |
CEO | Stephen Croskrey |
Employees | 257 |
Founded | 2014 |
Website | www.danimerscientific.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.